Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Cost Savings on Generic Drugs: Transparent Pric...
By
HEOR Staff Writer
June 18, 2024
Introduction Through its transparent, online direct-to-consumer pharmacy model, the Mark Cuban Cost Plus Drug Company (MCCPDC) has made substantial progress in the provisi...
Universal Early Parenting Programmes: Unraveling the Cost-Effectiveness
Enhancing Clinician Accuracy in EEG Pattern Classification with AI
Advancing Pneumococcal Disease Prevention in Japan with PCV20
The Power of Real-World Evidence: Bringing Everyday Health Data to Drug Appro...
Health equity insights for National Cancer Survivors Day
The Future of Peer Review in Scientific Manuscripts: Embracing Artificial Int...
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making
Enhancing Fairness in AI/ML Models for Healthcare Using Real-World Data
Self-Management of Vaginal Pessaries: A Viable Alternative for Pelvic Organ P...
Treatment Effect Estimation with AI: The CURE Framework
Use of AI in Genetic Diagnosis: Identifying Rare Diseases
South Africa’s Medical Technology Master Plan Launched
« Previous
1
…
12
13
14
15
16
…
29
Next »